Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: A Mendelian randomization analysis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Theodoratou, Evropi ^a,b   Palmer, Tom ^c   Zgaga, Lina ^a,b,d   Farrington, Susan M ^b   McKeigue, Paul ^a   Din, Farhat V N ^b   Tenesa, Albert ^b,e   Davey Smith, George ^c   Dunlop, Malcolm G ^b   Campbell, Harry ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; 25 HYDROXYERGOCALCIFEROL;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PREVALENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; COLORECTAL TUMOR; FEMALE; GENETICS; LIQUID CHROMATOGRAPHY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; RISK; RISK FACTOR; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY; UNITED KINGDOM;

25-HYDROXYVITAMIN D 2; ADULT; AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCOTLAND; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY;

EID: 84862017685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037662     Document Type: Article

References (46)

1. Jimenez-Lara AM, (2007) Colorectal cancer: potential therapeutic benefits of Vitamin D. Int J Biochem Cell Biol 39: 672-677.
2. Burleigh E, Potter J, (2006) Vitamin D deficiency in outpatients:-a Scottish perspective. Scott Med J 51: 27-31.
3. Zgaga L, Theodoratou E, Farrington SM, Agakov F, Tenesa A, et al. (2011) Diet, Environmental Factors, and Lifestyle Underlie the High Prevalence of Vitamin D Deficiency in Healthy Adults in Scotland and Supplementation Reduces the Proportion That Are Severely Deficient. J Nutr.
4. Report of the Panel on DRVs of the Committee on Medical Aspectsof Food Policy (COMA) (1991) Dietary Reference Values for Food Energy and Nutrients for the United Kingdom.
5. Pearce SH, Cheetham TD, (2010) Diagnosis and management of vitamin D deficiency. BMJ 340: b5664.
6. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B, (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28.
7. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, et al. (2007) The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85: 649-650.
8. Wagner CL, Greer FR, (2008) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122: 1142-1152.
9. Jimenez-Lara AM, (2007) Colorectal cancer: potential therapeutic benefits of Vitamin D. Int J Biochem Cell Biol 39: 672-677.
10. Park SY, Murphy SP, Wilkens LR, Nomura AM, Henderson BE, et al. (2007) Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. Am J Epidemiol 165: 784-793.
11. Gross MD, (2005) Vitamin D and calcium in the prevention of prostate and colon cancer: new approaches for the identification of needs. J Nutr 135: 326-331.
12. Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, et al. (2004) Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev 13: 538-545.
13. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, et al. (2008) Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding. Int J Cancer 123: 2170-2179.
14. Lee JE, Li H, Chan AT, Hollis BW, Lee IM, et al. (2011) Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 4: 735-743.
15. Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, et al. (2011) Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol 29: 1599-1606.
16. Davey-Smith G, Ebrahim S, (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1-22.
17. Didelez V, Sheehan N, (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16: 309-330.
18. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG, (2007) Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med.
19. Davey-Smith G, Ebrahim S, (2004) Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33: 30-42.
20. Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180-188.
21. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, et al. (2007) Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16: 684-693.
22. Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, et al. (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59: 1670-1679.
23. Wallace AM, Gibson S, de la HA, Lamberg-Allardt C, Ashwell M, (2010) Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 75: 477-488.
24. Knox S, Harris J, Calton L, Wallace AM, (2009) A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 46: 226-230.
25. Palmer TM, Sterne JA, Harbord RM, Lawlor DA, Sheehan NA, et al. (2011) Instrumental variable estimation of causal risk ratios and causal odds ratios in mendelian randomization analyses. Am J Epidemiol 173: 1392-1403.
26. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG, (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133-1163.
27. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, et al. (2007) Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 4: e352.
28. Sivakumaran S, Agakov F, Theodoratou E, Prendergast JG, Zgaga L, et al. (2011) Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet in press.
29. Touvier M, Chan DS, Lau R, Aune D, Vieira R, et al. (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20: 1003-1016.
30. Yin L, Grandi N, Raum E, Haug U, Arndt V, et al. (2011) Meta-analysis: Serum vitamin D and colorectal adenoma risk. Prev Med 53: 10-16.
31. Trivedi DP, Doll R, Khaw KT, (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326: 469.
32. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354: 684-696.
33. Ding EL, Mehta S, Fawzi WW, Giovannucci EL, (2008) Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int J Cancer 122: 1690-1694.
34. Pierce BL, Ahsan H, Vanderweele TJ, (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40: 740-752.
35. Benn M, Tybjaerg-Hansen A, Stender S, Frikke-Schmidt R, Nordestgaard BG, (2011) Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst 103: 508-519.
36. Breitling LP, Koenig W, Fischer M, Mallat Z, Hengstenberg C, et al. (2011) Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study. PLoS One 6: e22318.
37. Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 342: d548.
38. De Silva NM, Freathy RM, Palmer TM, Donnelly LA, Luan J, et al. (2011) Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes 60: 1008-1018.
39. Pfister R, Barnes D, Luben R, Forouhi NG, Bochud M, et al. (2011) No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia 54: 2561-2569.
40. Kivimaki M, Jokela M, Hamer M, Geddes J, Ebmeier K, et al. (2011) Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesity-associated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985-2004. Am J Epidemiol 173: 421-429.
41. Lawlor DA, Harbord RM, Tybjaerg-Hansen A, Palmer TM, Zacho J, et al. (2011) Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population Study of 53,221 adults. J Intern Med 269: 525-537.
42. Lewis SJ, Araya R, Smith GD, Freathy R, Gunnell D, et al. (2011) Smoking is associated with, but does not cause, depressed mood in pregnancy-a mendelian randomization study. PLoS One 6: e21689.
43. Dahl M, Vestbo J, Zacho J, Lange P, Tybjaerg-Hansen A, et al. (2011) C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax 66: 197-204.
44. Kivimaki M, Magnussen CG, Juonala M, Kahonen M, Kettunen J, et al. (2011) Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study. Int J Epidemiol 40: 470-478.
45. Mumby HS, Elks CE, Li S, Sharp SJ, Khaw KT, et al. (2011) Mendelian Randomisation Study of Childhood BMI and Early Menarche. J Obes 2011 180729.
46. McKeigue PM, Campbell H, Wild S, Vitart V, Hayward C, et al. (2010) Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome. Int J Epidemiol 39: 907-918.